about
The enlightenments from ITMIG Consensus on WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reportingKRAS, EGFR, PDGFR-α, KIT and COX-2 status in carcinoma showing thymus-like elements (CASTLE)Targeted therapy for advanced thymic tumors.Epidermal growth factor receptor, C-kit, and Her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the 2004 World Health Organization in patients treated with octreotide and prednisone: an Eastern CooperatiCurrent chemotherapy options for thymic epithelial neoplasms.Thymic malignancies: from clinical management to targeted therapies.Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.Chemotherapy and targeted agents for thymic malignancies.Radiotherapy for thymic carcinoma: adjuvant, inductive, and definitive.Targeted therapy for thymic epithelial tumors: a new horizon? Review of the literature and two cases reports.Anti-Apoptotic Signature in Thymic Squamous Cell Carcinomas - Functional Relevance of Anti-Apoptotic BIRC3 Expression in the Thymic Carcinoma Cell Line 1889c.Establishment and characterization of a novel cell line derived from human thymoma AB tumor.Successful Use of Erlotinib in Treating Recurrent Thymic Carcinoma: A Case Report.About thymic carcinomas: challenges in diagnosis and management.Long lasting efficacy of sorafenib in a heavily pretreated patient with thymic carcinoma.Diagnostic value of markers M2A, OCT3/4, AP-2gamma, PLAP and c-KIT in the detection of extragonadal seminomas.
P2860
Q26750202-398F3C5C-F376-470E-99F9-805F83F802B6Q33835833-1B281107-0A73-48CB-BCFA-EDDEB7C4D168Q34291929-203F623B-861D-4C6D-9EE7-9DB73570682AQ34701188-F0C98C0B-CE18-4BEE-9392-8E7AF2305D84Q36163988-F3C3915E-4B04-49AB-8BCF-92E03CB12BF9Q36910414-61E62513-AD63-41EB-9C23-504316B7F789Q37440960-08D9AE70-F65E-411C-A184-FAE7ECCDA687Q38010806-F8969F2A-657E-44F8-A57D-102E4BEF3E82Q38181146-97D5DEED-5DB7-4575-ADED-14AC4BA4606CQ38400475-F829201C-3398-4C7A-AE54-1B93E1EAA244Q39034212-3A63EA22-BAFA-457C-B906-AC664058B554Q39289980-7071CA0D-2921-4887-A319-452F2852FA56Q45327994-1FB49861-DD17-4338-BBB0-939FE9329C4EQ46375470-42CFF825-667E-41A2-8EC1-1E7515F54140Q51301560-D5909956-6F7B-49EE-846D-A44EAE3A2489Q52009470-3452AD53-8D10-4D8F-97AD-8312BC85F80F
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Tyrosine kinase receptor expression in thymomas.
@en
Tyrosine kinase receptor expression in thymomas.
@nl
type
label
Tyrosine kinase receptor expression in thymomas.
@en
Tyrosine kinase receptor expression in thymomas.
@nl
prefLabel
Tyrosine kinase receptor expression in thymomas.
@en
Tyrosine kinase receptor expression in thymomas.
@nl
P2093
P1476
Tyrosine kinase receptor expression in thymomas.
@en
P2093
John D Henley
Oscar W Cummings
Patrick J Loehrer
P2888
P304
P356
10.1007/S00432-004-0545-Z
P577
2004-02-05T00:00:00Z